"There is great potential for CHORP's research findings to provide patients, providers and policy makers with the evidence they need to make informed healthcare decisions."

Steven M. Witz, Ph.D., MPH
Director, Regenstrief Center

GEORGE AVERY, Ph.D.
Assistant professor of health and kinesiology

Avery's research interests revolve around healthcare quality management and regulation and public health preparedness, particularly the problem of defining and coordinating policies to strengthen the ability of the public health system to respond to emergencies such as infectious disease epidemics or bioterrorism. Contact info

SUSAN CHEN, Ph.D.
Assistant professor of agricultural economics

My research interests are in Health Economics, particularly in the evaluation of government health programs (such as the Social Security Disabiltiy Insurance Program) and in the study of the economics of obesity. Contact info

BRUCE CRAIG, Ph.D.
Professor of statistics

Craig's areas of interest include: Bayesian hierarchical modeling, Markov chain Monte Carlo, protein structure determination, design and analysis of microarray experiments, statistical education, spatial statistics and population modeling. Contact info

LAURA SANDS, Ph.D.
Professor of nursing
CHORP Co-director

Sands' research is focued on promoting optimal functioning in older adults, developing metrics for determining whether a patient is functioning optimally, and developing methods for detecting whether individual dementia patients benefit from pharmaceutical therapy designed to enhance cognitive functioning. She has also contributed to the development of instruments to assess quality of life in persons with dementia, patient satisfication and patient preferences for treatment. Contact info

JOSEPH THOMAS III
Professor of pharmacy
CHORP Co-director

Thomas' research is concentrated on management of pharmaceutical services, pharmaceutical product and service marketing, health policy and economic analysis of alternative financing and reimbursement arrangements for pharmaceutical products and/or services. He also is analyzing the impact of innovative pharmaceutical services upon health care outcomes and total healthcare expenditures. Contact info